Placeholder

This product is currently out of stock and unavailable.

SKU: N/A Category:

Global General Anesthesia Drugs Market Outlook (2013-2018)

  • Nov, 2013
  • pages: 268
  • formats:* PDF
  • Report ID: MRPH-10404

Product Description

Anesthesia meant the condition of having sensation blocked or temporarily taken away. This allow patient to undergo surgery and other procedures without distress and pain they would otherwise experience. Anesthesia includes two types like local anesthesia and general anesthesia. Local anesthesia inhibits within a specific location on the body, such as a tooth or the urinary bladder, General anesthesia refers to inhibition of sensory, motor and sympathetic nerve transmission at the level of the brain, resulting in unconsciousness and lack of sensation.
The research report particularly focuses on ketamine market across the globe. Under general anesthesia drugs category, drugs such as Propofol, midazolam & diazepam, fospropofol disodium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied.
The report meticulously analyzes the anesthesia drug market by distribution structure such as identification of sales volume, and legal tend in corporate sector, and by product analysis such as market share, global competition, and sale price.
This research report provides comprehensive advantages of general anesthesia drug market across the globe. The regions cover in this report are North America (U.S, Canada), Europe (Germany, France, Italy, U.K, Spain), Asia- pacific (Japan, India, China), and rest of world (Latin America, Middle East Africa).
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.

TABLE OF CONTENT

    1. 1 Introduction
      1. 1.1 Market Ecosystem
      2. 1.2 Report Elucidation
      3. 1.3 Market Buzz & Foreground
      4. 1.4 Research Methodology
        1. 1.4.1 Secondary Research
        2. 1.4.2 Primary Research
        3. 1.4.3 Market Analytics


  1. 2 Executive Summary

  2. 3 Market Insights
    1. 3.1 Drivers
    2. 3.2 Restraints
    3. 3.3 Opportunities
    4. 3.4 Challenges
    5. 3.5 Market Share Analysis
    6. 3.6 Market Trends
    7. 3.7 Burning Issues
  3. 4 Market Analysis
    1. 4.1 Market Usage
      1. 4.1.1 Ketamine: Global Details For Humans
        1. 4.1.1.1 Enumeration, By Types
        2. 4.1.1.2 Enumeration, By Item
  4. 5 Distribution structure
    1. 5.1 Global Ketamine Distribution Structure For Humans
    2. 5.2 Identification Of Sales Volume
      1. 5.2.1 Identification, By Manufacturers
      2. 5.2.2 Identification, By Distribution Channels
    3. 5.3 Major Legal Trends In Corporate Sector
      1. 5.3.1 Complete Details Pertaining Trends Associated With Manufacturers
        1. 5.3.1.1 Registration
        2. 5.3.1.2 Security
        3. 5.3.1.3 Labeling And Packaging
        4. 5.3.1.4 Inventory
        5. 5.3.1.5 Records
      2. 5.3.2 Complete Details Pertaining Trends Associated With Vendors
    4. 5.4 Main Product Category Enumeration
      1. 5.4.1 Ketamine
      2. 5.4.2 Other Brands
    5. 5.6 Market Share, By Key Products
    6. 5.7 Market Share, By Key Players
  5. 6 Product Analysis
    1. 6.1 Specific Local Anesthetic Market Segmentation
    2. 6.2 Market Share
      1. 6.2.1 Detailed Enumeration
      2. 6.2.2 Major Brands/Molecules
    3. 6.3 Global Competition
      1. 6.3.1 Key Competitors
      2. 6.3.2 Price
      3. 6.3.3 Major Brands
    4. 6.4 Sales Price
      1. 6.4.1 Manufacturer Price Of Ketamine (Hospitals)
      2. 6.4.2 Global Potential Buyers
      3. 6.4.3 Potential Buyers, By Each Country
  6. 7 Key Information
    1. 7.1 Import & Export Systems
      1. 7.1.1 Import Of Controlled Substances
        1. 7.1.1.1 Shipment Of Controlled Substances
        2. 7.1.1.2 Applicants For Import And Export Of Controlled Substances
      2. 7.1.2 Export Of Controlled Substances
        1. 7.1.2.1 Exception For Exportation For Special Scientific Purposes
      3. 7.1.3 Based On Tariffs
        1. 7.1.3.1 Custom Tariff For Import
      4. 7.1.4 Based On Transport
      5. 7.1.5 Customs Clearance
      6. 7.1.6 Non-tariff Barriers
    2. 7.2 Top Related Exhibitions
    3. 7.3 Potential Buyers Description
  7. 8 Company Profiles
    1. 8.1 Abbott Laboratories
    2. 8.2 Astrazeneca Plc
    3. 8.3 Baxter International, Inc
    4. 8.4 Bedford Laboratories
    5. 8.5 Bioniche Pharmaceuticals (Mylan Inc)
    6. 8.6 Eisai Co. Ltd
    7. 8.7 Hospira Inc
    8. 8.8 Jhp Pharmaceuticals Llc
  8. 9 Competitive Landsacpe
    1. 9.1 Introduction
    2. 9.2 Agreements, Partnerships & Collaborations
    3. 9.3 Investments & Expansions
    4. 9.4 Key Market Strategies
    5. 9.5 Mergers & Acquisitions
    6. 9.6 New Products Launches

LIST OF TABLES & FIGURES

LIST OF TABLES & FIGURES

DOWNLOAD SAMPLE

Download Sample

Please fill in the form below to receive the free sample pages of the report.

This website is secure and we do not share your personal information with any third party. Privacy Policy

NEED CUSTOMIZATION?

Need Customization?

Not satisfied with the defined report scope. No worries, we can customize this report for you.
Please fill in the form below and our research analyst will get in touch with you immediately.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Reviews

There are no reviews yet.

Be the first to review “Global General Anesthesia Drugs Market Outlook (2013-2018)”